Clinical Trial Update: Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium [Phase 4]

View source ↗

Summary

Phase 4 trial for improving CBCT imaging with gadoxetate disodium in liver SBRT has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Gadoxetate disodium (gadoxetate disodium)

Snippet

Sponsor: Slawa Cwajna | Conditions: Primary Liver Cancer, Metastatic Liver Cancer | Phase 4 | Status: WITHDRAWN